GRAIL, Inc. Deferred Income Tax Expense (Benefit)
GRAIL, Inc. (GRAL) reported Deferred Income Tax Expense (Benefit) of -$91.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- GRAIL, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$56.67M.
- GRAIL, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$34.55M.
- GRAIL, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$17.34M.
- GRAIL, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$29.74M.
- GRAIL, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$126.15M.
- GRAIL, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$134.25M.
- GRAIL, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$38.15M.
- GRAIL, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$39.06M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$56.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$91.22M 10-Q · filed 2026-08-06 | -$108.56M derived: sum of 3 quarters · filed 2026-08-06 | -$138.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$34.55M 10-Q · filed 2026-05-07 | -$51.89M derived: sum of 2 quarters · filed 2026-05-07 | -$81.63M derived: sum of 3 quarters · filed 2026-05-07 | -$120.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$17.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$47.08M derived: sum of 2 quarters · filed 2026-03-12 | -$85.95M derived: sum of 3 quarters · filed 2026-08-06 | -$126.15M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$29.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$68.61M derived: sum of 2 quarters · filed 2026-08-06 | -$108.81M 10-Q · filed 2025-11-13 | -$138.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$38.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$79.07M 10-Q · filed 2026-08-06 | -$108.33M derived: sum of 3 quarters · filed 2026-08-06 | -$155.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$40.20M 10-Q · filed 2026-05-07 | -$69.46M derived: sum of 2 quarters · filed 2026-05-07 | -$116.50M derived: sum of 3 quarters · filed 2026-05-07 | -$169.65M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$29.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$76.30M derived: sum of 2 quarters · filed 2026-03-12 | -$129.45M derived: sum of 3 quarters · filed 2026-03-12 | -$134.25M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$47.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$100.19M derived: sum of 2 quarters · filed 2025-11-13 | -$104.99M 10-Q · filed 2025-11-13 | -$109.01M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$53.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$57.95M 10-Q · filed 2025-08-13 | -$61.97M derived: sum of 3 quarters · filed 2026-03-12 | -$80.03M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$4.80M 10-Q · filed 2025-05-14 | -$8.82M derived: sum of 2 quarters · filed 2026-03-12 | -$26.89M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | -$4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$22.08M derived: sum of 2 quarters · filed 2026-03-12 | -$38.15M 10-K · filed 2025-03-05 | |
| 2023-10-01 | -$18.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$34.13M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$16.07M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | -$39.06M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |